Bisindolylmaleimide VIII, Acetate and Ro-31-7549
INHIBITORS
Product Details |
|
CAT No.# | CS-AR-00241 |
Category | Inhibitors |
CAS | 125313-65-7 |
Molecular Weight | 398.46 |
Molecular Formula | C24H22N4O2 |
Purity: | >98% |
Synonyms: | 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione |
Shipping: | Free Shipping for worldwide on order above 2000 USD |
COA / MSDS: | View COA MSDS |
The balance used are calibrated with weights traceable to National Standards NIST for accuracy |
Bisindolylmaleimide VIII, Acetate and Ro-31-7549
Worldwide Suppliers of Bisindolylmaleimide VIII, Acetate and Ro-31-7549
https://www.clearsynth.com/en/CSAR00241.html
Inhibitors
Clearsynth
CS-AR-00241
PEOPLE
ALSO SEARCHED FOR:
1.
propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylateProduct rating: 9 Bisindolylmaleimide VIII, Acetate and Ro-31-7549 based on 20 ratings
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)
This page contains information about Bisindolylmaleimide VIII, Acetate and Ro-31-7549 Cas 125313-65-7 and its Inhibitors.
Bisindolylmaleimide VIII, Acetate and Ro-31-7549 Bisindolylmaleimide VIII, Acetate and Ro-31-7549 Inhibitors of Bisindolylmaleimide VIII, Acetate and Ro-31-7549 https://www.clearsynth.com/en/CSAR00241.html Inhibitors Clearsynth 125313-65-7 https://www.clearsynth.com/en/temp/CS-AR-00241.jpg
"Products currently covered
by valid US Patents are offered for R&D use in accordance with
35 USC 271(e)+A13(1). Any patent infringement and resulting
liability is solely at buyer risk."